Lion Biotechnologies Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Genesis Biopharma Inc Announces Management Change-Form 8-K
Genesis Biopharma Inc reported in its Form 8-K that in connection with the Merger, effective July 24, 2013, Dr. Manish Singh, was appointed as Chief Executive Officer (CEO) and Chairman of the Board of the Company, to serve until his death, disability, resignation or replacement, and General Merrill McPeak ceased to hold the office of Interim Chief Executive Officer (CEO).
Latest Developments for Lion Biotechnologies Inc
- Lion Biotechnologies Inc Raises Approximately $23 Million In Private Financing
- Lion Biotechnologies Inc Provides Update On Phase II Results For Metastatic Melanoma
- Genesis Biopharma Inc Announces Completion Of Merger With Lion Biotechnologies
- Genesis Biopharma Inc Announces Resignation Of CEO-Form 8-K
- Share this
- Digg this